1、XF.Wang, YQ.Zhao, RC.Yang, JS.Wu, J.Sun, X.S.Zhang, QL.Ding, H.L.Ge and H.L.WANG#. The prevalence of factor VIII inhibitors and genetic aspects of inhibitor development in Chinese patients with haemophilia A. Haemophilia,2010;16:632-639
2、Wang X, Jin PP, Zhou T, Zhao YP, Ding QL, Wang DB, Zhao GM, Dai J, Wang HL, Ge HL#. MR Molecular Imaging of Thrombus: Development and Application of a Gd-based Novel Contrast Agent Targeting to P-selectin. Clin Appl Thromb Hemost,2010;16(2):177-183
3、Shen LS, Wang J, Shen DF, Yuan XL, Dong P, Li MX, Xue J, Zhang FM, Ge HL#, Xu D. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3+ and suppress effector T cell proliferation and contribute to gastric cancers progression. Clin Immunol,2009;131(1):109-118
4、Qingfei Wang , Meixing Li, Ying Wang, Yong Zhang, Shu Jin, Guohua Xie, Zhengchun Liu, Shujun Wang, Huizhen Zhang, Lisong Shen, Hailiang Ge#. RNA interference targeting CML66, a novel tumor antigen, inhibits proliferation, invasion and metastasis of HeLa cells. . Cancer Litt.,2008;(269):127-138
5、Shu Jin, Ying Wang, Yong Zhang, Huizhen Zhang, Shujun Wang, Jun-qiao Tang, Huijuan Chen, Hailiang Ge#. Humoral immune responses against tumor-associated antigen OVA66 originally defined by SEREX and its potentiality in cellular immunity. Cancer Science,2008;99(8):1670-1678
6、Guohua Xie, Shujun Wang, Ying Wang, Yong Zhang, Huizhen Zhang, Shu Jin, Qingfei Wang, Zhengchun Liu, and Hailiang Ge#. Fas ligand gene transfer enhances the survival of tissue-engineered chondrocyte allografts in mini-pigs. Transplant Immunology,2008;19:145-151
|
